Surf: Open label, randomized multi-centre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma (mRCC)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Surf: Open label, randomized multi-centre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma (mRCC) |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Mouillet G., Maurina T., Paillard M-J., Montcuquet P., T. Hon NTan, Almotlak H., Stein U., Berthod D., Robert E., Meurisse A., Bonnetain F., Thiery-Vuillemin A. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw373.70 |